Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
The State Street Health Care Select Sector SPDR ETF (XLV +2.63%) provides broad, low-cost exposure to the entire healthcare sector, whereas the Invesco Pharmaceuticals ETF (PJP +2.84%) offers a concentrated bet on 29 specific pharmaceutical…
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
Choosing between Dyne Therapeutics (DYN +5.87%) and Recursion Pharmaceuticals (RXRX +3.54%) requires balancing the potential of targeted muscle-tissue therapies against the broad, data-driven power of artificial intelligence in drug discovery. Dyne…
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Nano Banana Pro prompted by THE DECODER Anthropic is launching its own drug development programs for neglected diseases that the traditional pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan says new AI models could cut…
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
The VanEck Pharmaceutical ETF (PPH +3.19%) offers a more cost-efficient entry point and higher income potential, while the Invesco Pharmaceuticals ETF (PJP +2.84%) has recently demonstrated stronger price appreciation for investors seeking sector…
Not just IT: How Indian firms quietly became a $40 billion force in America
One of the foremost examples is the Tata Group, which was an early pioneer in the list of companies investing in America, as the group established its permanent US presence by setting up its office in New York City in 1945. However, outward FDI…
Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying
Viking Therapeutics (VKTX 0.11%) is one of the hopefuls in a very exciting pharmaceutical and biotech space right now: the weight loss drug market. Today, pharma giants Eli Lilly and Novo Nordisk dominate this area with their drugs, but demand is…
Brookfield Renewable: Simplification Catalyst May Favor Brookfield Renewable Partners
Brookfield Renewable Corporation is evaluating a merger with Brookfield Renewable Partners to create a single publicly traded entity. BEPC trades at a 7.7% premium to BEP despite identical economic exposure, payments, and platform access, largely…
McKesson: The Healthcare Supplier On My Buy List This Summer, As Growth Accelerates (NYSE:MCK)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
What's powering India's stock market rally? Nifty and sensex post strong weekly gains | Dynamite News
Post Published By: Donika Singh Updated: 4 July 2026, 9:59 AM IST New Delhi: The Indian equity benchmarks posted a fourth consecutive week of gains, over sustained correction in crude oil prices and expectations of a more favourable global interest…
PepsiCo, Delta Air Lines To Report Earnings; FOMC's Minutes Of The Meeting In Focus
Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs…
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
Biogen (BIIB +3.04%) built itself into a biotech giant thanks to its portfolio of multiple sclerosis (MS) drugs -- but in biotech and pharma, revenue growth depends on the life of a patent. Once a company loses exclusivity, generics or biosimilars…
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Healthcare is changing through AI and personalized cell therapy. Which of these high-growth innovators represents the better risk-adjusted opportunity for your portfolio today as you evaluate Heartflow Inc. (HTFL 8.94%) and Iovance Biotherapeutics…
302,995 Shares in Teva Pharmaceutical Industries Ltd. $TEVA Purchased by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd bought a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 302,995 shares of…
Smithbridge Asset Management Inc. DE Has $5.67 Million Holdings in Eli Lilly and Company $LLY
Smithbridge Asset Management Inc. DE trimmed its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 51.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…
Root Financial Partners LLC Sells 1,304 Shares of Eli Lilly and Company $LLY
Root Financial Partners LLC reduced its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 44.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor…
Receive a Daily briefing on Pharma Industry News
Get Started